0001225208-22-003666.txt : 20220301 0001225208-22-003666.hdr.sgml : 20220301 20220301160302 ACCESSION NUMBER: 0001225208-22-003666 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDermott Michael CENTRAL INDEX KEY: 0001902464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 22697858 MAIL ADDRESS: STREET 1: C/O PFIZER INC. CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: 235 EAST 42ND STREET STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2022-02-26 0000078003 PFIZER INC PFE 0001902464 McDermott Michael PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Executive Vice President Common Stock 2022-02-26 4 M 0 12340.0000 25.6000 A 83530.0000 D Common Stock 2022-02-26 4 F 0 2372.0000 47.7200 D 81158.0000 D Common Stock 2022-02-26 4 F 0 5761.0000 50.6400 D 75397.0000 D Common Stock 2022-02-28 4 F 0 1384.0000 46.9400 D 74013.0000 D Stock Appreciation Rights 25.6000 2022-02-26 4 M 0 12340.0000 0.0000 D 2022-02-26 2022-02-26 Common Stock 12340.0000 0.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Price is the closing price of Pfizer common stock on February 25, 2022. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Susan E. Grant, by power of atty., for Michael McDermott 2022-03-01